- Home »
- Quarterly Results »
- Nexus Surgical & Medicare Q1 Results Income ₹59.33 Lakhs & Net Profit ₹5.84 Lakhs
Nexus Surgical & Medicare Q1 Results Income ₹59.33 Lakhs & Net Profit ₹5.84 Lakhs
Nexus Surgical & Medicare Q1 Results show total income of ₹59.33 lakhs and expenses of ₹51.05 lakhs and they earned a profit before tax of ₹8.29 lakhs and a net profit of ₹5.84 lakhs.
by Ruksana
Updated Aug 28, 2024
Table of Content
Nexus Surgical & Medicare Q1 Result
Nexus Surgical & Medicare Q1 Results: Nexus Surgical & Medicare released its financial results for the quarter ending June 30, 2024. For this period, the company earned ₹59.80 lakhs from sales and services, which is less compared to ₹176.03 lakhs earned in the previous quarter. They had a small negative other income of ₹0.46 lakhs, making the total income ₹59.33 lakhs.
Nexus Surgical & Medicare's expenses include ₹41.60 lakhs for buying stock, a reduction in cost of materials by ₹20.04 lakhs, ₹5.94 lakhs for employee salaries, ₹0.10 lakhs for depreciation, and ₹23.49 lakhs for other expenses. This totals ₹51.05 lakhs in expenses, which is lower compared to ₹164.04 lakhs in the previous quarter.
After covering these expenses, the company made a profit of ₹8.29 lakhs before taxes. They paid ₹2.47 lakhs in current tax and ₹0.06 lakhs in deferred tax, resulting in a net profit of ₹5.84 lakhs. The company's total comprehensive income, which includes profits and other adjustments, was ₹8.99 lakhs for this quarter. The company’s paid-up equity share capital is ₹54 lakhs, with an earnings per share (EPS) of ₹0.16, up from ₹0.11 in the previous quarter.
Here is a simplified summary of the unaudited financial results for Nexus Surgical and Medicare for the quarter ended June 30, 2024:
Particulars |
June 30, 2024 (Unaudited) |
March 31, 2024 (Audited) |
June 30, 2023 (Unaudited) |
March 31, 2024 (Audited) |
Income |
||||
Sales and Services |
59.80 |
176.03 |
106.08 |
347.43 |
Other Income |
(0.46) |
- |
0.75 |
2.68 |
Total Income |
59.33 |
176.03 |
106.83 |
350.11 |
Expenses |
||||
Purchase of Stock-in-Trade |
41.60 |
21.11 |
7.67 |
92.51 |
Cost of Materials Consumed |
(20.04) |
34.42 |
(1.58) |
(33.15) |
Employee Benefits Expense |
5.94 |
5.51 |
5.31 |
23.99 |
Depreciation and Amortization Expense |
0.10 |
0.06 |
0.04 |
0.19 |
Other Expense |
23.49 |
102.89 |
91.80 |
237.49 |
Total Expenses |
51.05 |
164.04 |
103.24 |
321.03 |
Profit Before Tax |
8.29 |
11.99 |
3.59 |
29.07 |
Current Tax |
2.47 |
3.00 |
0.90 |
7.70 |
Tax for Earlier Years |
(0.08) |
- |
- |
(0.08) |
Deferred Tax |
0.06 |
- |
- |
0.12 |
Tax Expenses |
2.45 |
3.00 |
0.90 |
7.74 |
Profit After Tax |
5.84 |
8.99 |
2.69 |
21.33 |
Other Comprehensive Income |
||||
Items Not Reclassified to Profit/Loss |
- |
- |
- |
- |
Items Reclassified to Profit/Loss |
- |
- |
- |
- |
Total Other Comprehensive Income |
- |
- |
- |
- |
Total Comprehensive Income |
8.99 |
5.84 |
2.69 |
21.33 |
Paid-up Equity Share Capital |
54 |
547.19 |
7.19 |
547.19 |
Other Equity |
(490.56) |
- |
- |
- |
Basic and Diluted EPS (₹) |
0.16 |
0.11 |
0.05 |
0.39 |
Source: Here
For More Q1 Results check our Twitter Page
Visit our website for more Q1 results
Nexus Surgical & Medicare Financial Performance
Nexus Surgical & Medicare has a market capitalization of ₹9.31 crore, which means the total value of all its shares is ₹9.31 crore. The current price of one share of Nexus Surgical & Medicare is ₹17.00. The highest price at which the stock has traded in recent times is ₹21.70, while the lowest price is ₹8.10.
Here's the financial summary for the company:
Metric |
Value |
Market Cap |
₹9.31 Cr. |
Current Price |
₹17.0 |
High / Low |
₹21.7 / ₹8.10 |
Stock P/E |
33.2 |
Book Value |
₹1.02 |
Dividend Yield |
0.00 % |
ROCE |
65.9 % |
ROE |
46.2 % |
Face Value |
₹10.0 |
Quarterly Results
Nexus Surgical & Medicare table shows the financial results across different quarters. It includes figures for sales, expenses, operating profit, and net profit. For each quarter, you see how much money the company made (sales) and how much it spent (expenses). The operating profit shows the company's earnings before taxes and other costs.
Here's the quarterly financial data for December 2023, March 2024, and June 2024:
Metric |
Dec 2023 |
Mar 2024 |
Jun 2024 |
Sales (Rs. Crores) |
1.45 |
0.60 |
1.76 |
Expenses (Rs. Crores) |
1.40 |
0.52 |
1.64 |
Operating Profit (Rs. Crores) |
0.05 |
0.08 |
0.12 |
OPM % |
3.45% |
13.33% |
6.82% |
Other Income (Rs. Crores) |
0.01 |
0.00 |
0.00 |
Interest (Rs. Crores) |
0.00 |
0.00 |
0.00 |
Depreciation (Rs. Crores) |
0.00 |
0.00 |
0.00 |
Profit Before Tax (Rs. Crores) |
0.06 |
0.08 |
0.12 |
Tax % |
33.33% |
25.00% |
25.00% |
Net Profit (Rs. Crores) |
0.05 |
0.06 |
0.09 |
EPS (Rs.) |
0.09 |
0.11 |
0.16 |
About Nexus Surgical & Medicare
Nexus Surgical and Medicare, founded on January 8, 1992, is a company based in India with the CIN L33100MH1992PLC328367. It became publicly listed on the Bombay Stock Exchange (BSE) on January 8, 2015, with the code 538874. The company specializes in importing and marketing high-quality surgical and pharmaceutical products at affordable prices. They primarily deal in disposable syringes (with and without needles) and pouches for storing sterilized equipment and materials.
Nexus Surgical and Medicare stands out in the market due to its vast experience, direct sourcing of quality products from overseas manufacturers, a broad distribution network, competitive pricing, and timely delivery of products.
Nexus Surgical and Medicare's mission is to make healthcare products both convenient and affordable, striving to be the go-to place for all hospital needs. Nexus values humility, empathy, adaptability, remarkable service, and transparency. These core values guide their actions and are appreciated by both employees and customers.
Nexus Surgical and Medicare's vision is to build global connections by offering effective products at competitive prices and to be a central hub where hospitals can find everything they need. They aim to enhance patient health by delivering high-quality, safe, and effective products that meet hospital standards.
Nexus Surgical & Medicare Q1 Results - FAQs
1. What was Nexus Surgical & Medicare’s total income for Q1 2024?
Nexus Surgical & Medicare’s total income for Q1 2024 was ₹59.33 lakhs.
2. How did Nexus Surgical & Medicare’s expenses change from the previous quarter?
Nexus Surgical & Medicare’s expenses decreased from ₹164.04 lakhs in the previous quarter to ₹51.05 lakhs.
3. What is the EPS of Nexus Surgical & Medicare for Q1 2024?
The EPS for Nexus Surgical & Medicare in Q1 2024 is ₹0.16.
4. How much did Nexus Surgical & Medicare earn from sales and services in Q1 2024?
Nexus Surgical & Medicare earned ₹59.80 lakhs from sales and services in Q1 2024.
5. What were Nexus Surgical & Medicare’s other expenses for Q1 2024?
Nexus Surgical & Medicare’s other expenses for Q1 2024 were ₹23.49 lakhs.
6. What was Nexus Surgical & Medicare’s profit before tax for Q1 2024?
Nexus Surgical & Medicare’s profit before tax for Q1 2024 was ₹8.29 lakhs.
7. What was the market capitalization of Nexus Surgical & Medicare?
The market capitalization of Nexus Surgical & Medicare is ₹9.31 crore.
8. How much did Nexus Surgical & Medicare pay in current tax for Q1 2024?
Nexus Surgical & Medicare paid ₹2.47 lakhs in current tax for Q1 2024.
9. What was Nexus Surgical & Medicare’s total comprehensive income for Q1 2024?
Nexus Surgical & Medicare’s total comprehensive income for Q1 2024 was ₹8.99 lakhs.
10. What is Nexus Surgical & Medicare’s return on equity (ROE)?
Nexus Surgical & Medicare’s ROE is 46.2%.